Specialization

At Ferrer we specialize in own brand prescription drugs, mainly for hospital use

orange

Ferrer is a pharmaceutical company that aims to have a positive impact on society by reinvesting a large part of our profits in social and environmental impact initiatives, as well as in our people.

To fulfil that purpose, we offer trusted treatment solutions, with a growing focus on vascular and interstitial lung diseases and neurological disorders. 

In addition, at Ferrer, we cover every link in the value chain of medicines and pharmaceuticals: research and development, distribution and marketing, and purchasing and supply.

In our efforts to provide significant differential value to people suffering from serious ailments, at Ferrer, we have established a clear global strategy for developing a portfolio of innovative products capable of transforming the lives of patients suffering from severe and debilitating diseases. 

At Ferrer, we leverage our cumulative knowledge and experience to develop products in two main treatment areas: vascular and interstitial lung diseases and neurological disorders.

Both areas include rare or low-prevalence diseases that are often lacking in appropriate and/or authorised treatments. Accordingly, Ferrer's commitment to research and development of treatments in these areas is crucial for improving the lives of the many patients affected and for efficiently managing healthcare resources.

 

We mainly offer real innovation therapeutic solutions across 3 spheres:

A core element of Ferrer's business strategy is the company's continued use of its knowledge and experience to add value for healthcare professionals and patients. That's why Ferrer focuses on marketing branded pharmaceutical products with innovative and distinguishing features.

Ferrer's experience and knowledge make a difference in five treatment areas: pulmonary hypertension, the nervous system, pain, cardiometabolism, gastroenterology and dermatology. In these areas, Ferrer offers trusted products that meet the highest European quality standards. It manufactures many of these products itself.

Key products and brands worldwide

By therapeutic area, drug substance and brands marketed in different countries

Nervous system

  • Inhaled loxapine
  • Cytidine, uridina
  • Citicoline
  • Adasuve
  • Nucleo / Keltican
  • Somazina / Ceraxon / Zynapse

Cardiology

  • Treprostinil
  • Cangrelor
  • Clevidipine
  • Omega-3 polyunsaturated fatty acids
  • Enalapril maleate / Nitrendipine
  • Polypill (ASA, ramipril and atorvastatin [or simvastatin])
  • Remodulin
  • Kengrexal
  • Cleviprex stand
  • Omacor
  • Eneas
  • Trinomia / Sincronium

Dermatology

  • Sertaconazole
  • Ozenoxacin
  • Dermofix / Sertopic
  • Ozanex / Xepi / Dubine

Gastroenterology

  • Levosulpiride
  • Racecadotril
  • Dislep
  • Hidrasec, Tiorfan

Pain (Spain)

  • Paracetamol
  • Fentanyl citrate
  • Gelocatil line
  • Abfentiq, Kaptic
Last modification
08/07/2021